BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23452939)

  • 1. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
    Li X; Kang X; Deng Q; Cai J; Wang Z
    Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects.
    Murase M; Uemura T; Gao M; Inada M; Funabashi T; Hirahara F
    Endocr J; 2005 Feb; 52(1):131-7. PubMed ID: 15758569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?
    Parlakgumus HA; Kilicdag EB; Bolat FA; Haydardedeoglu B; Parlakgumus A
    Arch Gynecol Obstet; 2015 Jun; 291(6):1403-10. PubMed ID: 25472738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nu/nu athymic mice.
    Lin QY; Wang YF; Weng HN; Sheng XJ; Jiang QP; Yang ZY
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):894-903. PubMed ID: 23125082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a GnRH agonist on follicular dynamics and response to FSH stimulation in prepubertal calves.
    Dufour JJ; Mermillod P; Mariana JC; Romain RF
    Reprod Nutr Dev; 1999; 39(1):133-44. PubMed ID: 10222504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments.
    Maldonado LG; Franco JG; Setti AS; Iaconelli A; Borges E
    Fertil Steril; 2013 May; 99(6):1615-22. PubMed ID: 23394779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study.
    Del Gadillo JC; Siebzehnrübl E; Dittrich R; Wildt L; Lang N
    Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):179-83. PubMed ID: 11950487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O; Gordon K; Williams RF; Hodgen GD
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
    Xing W; Lin H; Li Y; Yang D; Wang W; Zhang Q
    PLoS One; 2015; 10(10):e0140286. PubMed ID: 26468951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
    Matsuo G; Ushijima K; Shinagawa A; Takahashi S; Fujiyoshi N; Takemoto S; Terada A; Fukui A; Kamura T
    Kurume Med J; 2007; 54(1-2):25-9. PubMed ID: 18332593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
    European and Middle East Orgalutran Study Group
    Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide.
    Lemos CN; Reis FM; Pena GN; Silveira LC; Camargos AF
    Reprod Biol Endocrinol; 2010 May; 8():51. PubMed ID: 20482803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
    Atakul T; Tayyar AT; Turan ÖD; Çelik SY; Yılmaz M; Küçük M; Yüksel H; Demirci B
    Gynecol Endocrinol; 2021 Jan; 37(1):46-50. PubMed ID: 32283955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.